MindWalk Holdings Corp.

NASDAQ:HYFT

Biotechnology

Healthcare
$1.08 +0.33%

+$0.01 today

Market cap
$50.88M
Beta
0.82
P/E (TTM)
-8.1
EPS (TTM)
-$0.26
52W Low $0.82High $3.25

Volume 0.20M

Average 0.32M

HYFT Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

MindWalk Holdings Corp.NASDAQ: HYFT

Operating Expenses · Q3 FY2026 · quarter ended Jan 2026

Operating expenses declines year over year

Q3 FY2026 operating expenses of CA$6.04M fell 8.3% year over year, behind the -5.4% change in trailing-twelve-month operating expenses. Sequentially, it rose 11.3% from the prior quarter. Over 3 fiscal years it compounded at -2.4% a year.

Context

  • Operating expenses amounted to 105.0% of revenue in FY2025, down 0.3 pp from a year earlier.
  • Operating expenses increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -8.3% toward the trailing-twelve-month pace of -5.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJan 2026
CA$6.04M+11.3% QoQ
Last fiscal yearApr 2025
CA$25.74M-0.3% YoY
LTMJan 2026
CA$23.06M-5.4% YoY
Operating Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-8.3%——
1 year-0.3%——
3-year CAGR-2.4%——
5-year CAGR——
10-year CAGR——

Operating Expenses history

CAD · from the income statement

Latest · FY2025
25.74M CAD
Year-over-year change
-0.3%
4-year CAGR
+13.1%

Operating Expenses vs competitors

How HYFT compares with its peers on the latest reported figures

  • Peers report in different currencies, so operating expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -5.4% is the 5th highest of 9, against a peer median of -5.5%.
  • Operating expenses amounts to 125.6% of revenue for HYFT, versus a peer median of 8375.9%.
HYFT Competitors
Operating Expenses for HYFT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
FBIOFortress Biotech, Inc.LTM Mar 2026$98.5M USD-27.0%-23.2%148.9%
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$92.88M USD-4.0%+25.5%—
ALXOALX Oncology Holdings Inc.LTM Mar 2026$91.02M USD-33.2%-6.5%—
CAMPCAMP4 Therapeutics CorporationLTM Mar 2026$55.03M USD+0.4%—1398.8%
ATYRaTyr Pharma, Inc.LTM Mar 2026$50.96M USD-7.1%+11.4%26818.9%
UNCYUnicycive Therapeutics, Inc.LTM Mar 2026$29.76M USD-3.7%+15.1%—
HYFTMindWalk Holdings Corp.LTM Jan 2026CA$23.06M CAD-5.4%-2.4%125.6%
CLNNClene Inc.LTM Mar 2026$20.57M USD-27.1%-21.9%15353.0%
BYSIBeyondSpring Inc.LTM Mar 2026$8.55M USD+19.5%-38.8%—
Peer median (excluding HYFT) —-5.5%-6.5%8375.9%

Competitors are the stored peer set for HYFT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Apr 2021
FY2022
Apr 2022
FY2023
Apr 2023
FY2024
Apr 2024
FY2025
Apr 2025
Revenue17.91M19.36M20.67M24.52M24.52M
Cost of Revenue6.37M8.38M9.1M12.47M10.97M
Gross Profit11.54M10.98M11.56M12.05M13.55M
Gross Margin64.4%56.7%56.0%49.2%55.3%
Research & Development1.97M7.66M14.1M4.04M4.94M
Selling, General & Admin13.27M18.06M18.99M19.14M19.03M
Operating Expenses15.71M27.66M37.17M25.82M25.74M
Depreciation & Amortization3.71M3.77M6.69M5.74M5.12M
EBITDA(1.42M)(11.99M)(21.04M)(22.95M)(28.86M)
EBITDA Margin-7.9%-61.9%-101.8%-93.6%-117.7%
Operating Income(4.18M)(16.67M)(25.61M)(13.76M)(12.2M)
Operating Margin-23.3%-86.1%-123.9%-56.1%-49.7%
Interest Income265.01K279K122K23K0
Interest Expense602.37K85K30K19K9.91K
Other Income / Expenses(1.82M)825K(2.14M)(14.94M)(22.07M)
Income Before Tax(6M)(15.85M)(27.75M)(28.7M)(34.27M)
Pre-Tax Margin-33.5%-81.8%-134.3%-117.1%-139.8%
Income Tax Expense1.35M861K(1.19M)(2.59M)(4.03M)
Net Income(7.34M)(16.71M)(26.56M)(26.12M)(30.23M)
Net Margin-41.0%-86.3%-128.5%-106.5%-123.3%
EPS (Basic)(0.45)(0.87)(1.07)(1.03)(0.90)
EPS (Diluted)(0.45)(0.87)(1.07)(1.03)(0.90)
Weighted Avg Shares16.47M19.69M24.9M25.64M33.39M
Weighted Avg Shares (Diluted)16.47M19.69M24.9M25.64M33.39M

MindWalk Holdings Corp.

NASDAQ:HYFT

Intrinsic Alpha fair value

Locked

Current Price

$1.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.